Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07664228 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

I-FABP as a Predictor of Gastrointestinal Involvement in Pediatric IgA Vasculitis

Study acronym: IFABP-IgAV
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This prospective observational study aims to evaluate plasma intestinal fatty acid-binding protein (I-FABP) levels in children with IgA vasculitis and investigate their association with gastrointestinal involvement. Blood samples will be collected at diagnosis and during follow-up 2-4 weeks later. The study will assess the potential value of plasma I-FABP as a biomarker for gastrointestinal involvement in pediatric IgA vasculitis.
Trial Details
NCT Number NCT07664228
Lead Sponsor Bursa City Hospital
Conditions
(from sponsor)		 IgA Vasculitis, Gastrointestinal Involvement
Related terms IgA Vasculitis
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov